Infant Nutrition Hydrolysate Ingredients Market

Infant Nutrition Hydrolysate Ingredients Market Size, Market Forecast and Outlook By FMI

The infant nutrition hydrolysate ingredients market was valued at USD 347.00 Million in 2025, projected to reach USD 369.21 Million in 2026, and is forecast to expand to USD 686.57 Million by 2036 at a 6.40% CAGR. As per FMI, the infant nutrition hydrolysate ingredients market is driven by rising CMPA diagnosis rates and pediatric allergy management guidelines recommending extensively hydrolyzed formula as the first-line feeding option. Powder form holds 58.3% share in 2026, consistent with manufacturing and storage advantages that dry hydrolysate ingredients offer to infant formula producers. Infant formula accounts for 36.7% of application share, representing the core demand driver where hydrolysate ingredients must meet stringent safety and nutritional specifications.

FMI opines that offline retail commands 62.4% of distribution channel share, reflecting the critical role of pharmacy and pediatrician recommendation in the hypoallergenic infant formula purchase journey. Online retail is the fastest-growing channel as parents seeking specialized formula products increasingly research and purchase through e-commerce platforms. China leads country-level growth at 8.6% CAGR, driven by rising CMPA awareness, expanding domestic hydrolysate manufacturing capacity, and government initiatives to improve domestic infant formula quality.

Summary of Infant Nutrition Hydrolysate Ingredients Market

• Infant Nutrition Hydrolysate Ingredients Market Definition
  • Infant nutrition hydrolysate ingredients are enzymatically hydrolyzed protein preparations specifically manufactured for use in hypoallergenic infant formula, baby food, and clinical pediatric nutrition products. These ingredients deliver pre-digested protein peptides that reduce allergenic potential in infants with confirmed or suspected cow milk protein allergy (CMPA).
• Demand Drivers in the Market
  • Rising CMPA diagnosis rates and updated pediatric allergy guidelines recommending extensively hydrolyzed formula drive formula manufacturer demand for specification-grade hydrolysate ingredients.
  • Government infant formula quality initiatives in China and the EU create regulatory frameworks incentivizing domestic hydrolysate ingredient manufacturing.
  • Clinical nutrition companies develop specialized hydrolysate-based pediatric feeding products for preterm infants, expanding the application beyond standard hypoallergenic formula.
• Key Segments Analyzed in the FMI Report
  • Powder in form: 58.3% share in 2026, reflecting the established supply chain position and cost-competitive processing infrastructure.
  • Offline Retail in distribution channel: 62.4% share in 2026, driven by concentrated end-use demand across the primary application category.
  • China: 8.60% compound growth, the fastest country-level expansion in the forecast period.
• Analyst Opinion at FMI
  • FMI analysts assess that the infant nutrition hydrolysate ingredients market is concentrated among a small number of global dairy ingredient companies (FrieslandCampina, Nestle, Danone, Abbott) controlling both hydrolysate manufacturing and downstream infant formula brands. This vertical integration creates barriers to entry. Clinical validation requirements add 3 to 5 years of development time before commercial launch, reinforcing incumbent advantages. Chinese domestic producers are investing in hydrolysis technology to reduce import dependence.
• Strategic Implications / Executive Takeaways
  • Dairy ingredient companies should invest in enzymatic hydrolysis process control to achieve consistent peptide molecular weight profiles meeting tightening clinical specifications.
  • Infant formula brands should fund clinical tolerance studies for proprietary hydrolysate formulations building the evidence base pediatricians require for CMPA feeding recommendations.
  • Supply chain teams should qualify secondary hydrolysate ingredient suppliers and establish safety stock protocols to mitigate production disruption risk.
• Methodology
  • Primary Research: Analysts conducted interviews with procurement directors, formulation scientists, and supply chain managers across key consumption regions to validate adoption timelines.
  • Desk Research: Data collection aggregated regulatory filings, trade statistics, industry standards publications, and company annual reports from primary public sources.
  • Market-Sizing and Forecasting: Baseline values derive from a hybrid top-down and bottom-up methodology combining production volume data with regional consumption pattern analysis.

All major consumption markets reflect distinct growth trajectories. China is projected to grow at 8.60% CAGR through 2036. India is projected to grow at 8.00% CAGR through 2036. Germany is projected to grow at 7.40% CAGR through 2036. France is projected to grow at 6.70% CAGR through 2036. UK is projected to grow at 6.10% CAGR through 2036. USA is projected to grow at 5.40% CAGR through 2036. Brazil is projected to grow at 4.80% CAGR through 2036. Growth rate differentials reflect variations in regulatory maturity, end-use industry concentration, and supply chain infrastructure development across these geographies.

Infant Nutrition Hydrolysate Ingredients Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 369.21 Million
Industry Value (2036)	USD 686.57 Million
CAGR (2026-2036)	6.40%

Infant Nutrition Hydrolysate Ingredients Market Definition

Infant nutrition hydrolysate ingredients are enzymatically hydrolyzed protein preparations specifically manufactured for use in hypoallergenic infant formula, baby food, and clinical pediatric nutrition products. These ingredients deliver pre-digested protein peptides that reduce allergenic potential in infants with confirmed or suspected cow milk protein allergy (CMPA).

Infant Nutrition Hydrolysate Ingredients Market Inclusions

Market scope includes global and regional revenue estimates for infant nutrition hydrolysate ingredients segmented by form (powder, liquid), distribution channel (offline retail, online retail), and application (infant formula, baby food, clinical nutrition). The forecast period covers 2026 to 2036 with country-level demand analysis.

Infant Nutrition Hydrolysate Ingredients Market Exclusions

The scope excludes intact (non-hydrolyzed) milk protein ingredients used in standard infant formula. Amino acid-based formulas that bypass protein hydrolysis entirely are outside the analytical boundary. Adult clinical nutrition hydrolysate products are also excluded.

Infant Nutrition Hydrolysate Ingredients Market Research Methodology

• Primary Research: Analysts conducted interviews with procurement directors, formulation scientists, and supply chain managers across key consumption regions to validate adoption timelines.
• Desk Research: Data collection aggregated regulatory filings, trade statistics, industry standards publications, and company annual reports from primary public sources.
• Market-Sizing and Forecasting: Baseline values derive from a hybrid top-down and bottom-up methodology combining production volume data with regional consumption pattern analysis.
• Data Validation and Update Cycle: Projections are tested against publicly reported trade data and company revenue disclosures to maintain forecast accuracy.

Why is the Infant Nutrition Hydrolysate Ingredients Market Growing?

The infant nutrition hydrolysate ingredients market is experiencing steady expansion, driven by rising global awareness of early-life nutrition and the health benefits of hydrolyzed proteins for infants with sensitive digestive systems or allergies. Growing parental preference for products that promote improved digestion, reduced allergenic potential, and enhanced nutrient absorption is fueling market adoption. Advances in protein hydrolysis technology are enabling the production of ingredients with better functional properties, taste, and nutrient retention, increasing their acceptance in both developed and emerging markets.

Regulatory support for hypoallergenic and specialized infant formulas, combined with increased availability in mainstream retail and e-commerce channels, is broadening consumer access. Manufacturers are investing in innovative formulations that meet international nutritional guidelines while catering to regional preferences and price sensitivities.

With birth rates stabilizing in some regions but rising in others, coupled with a strong emphasis on premiumization in infant nutrition products, the market is positioned for sustained growth Strategic collaborations between ingredient suppliers and infant formula producers are expected to further accelerate innovation and market penetration in the coming years.

Segmental Analysis

The infant nutrition hydrolysate ingredients market is segmented by form, distribution channel, application, and geographic regions. By form, infant nutrition hydrolysate ingredients market is divided into powder and liquid. In terms of distribution channel, infant nutrition hydrolysate ingredients market is classified into offline retail and online retail. Based on application, infant nutrition hydrolysate ingredients market is segmented into infant formula, baby food, clinical nutrition, and others. Regionally, the infant nutrition hydrolysate ingredients industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Powder Form Segment

The powder form segment is projected to hold 58.3% of the infant nutrition hydrolysate ingredients market revenue share in 2026, making it the leading form type. This leadership is being driven by the product’s extended shelf life, ease of transportation, and cost-effectiveness compared to liquid alternatives. Powder formulations offer greater stability during storage and shipping, ensuring nutrient integrity until preparation.

Their convenience for portion control and the ability to reconstitute with water or milk make them a preferred choice among caregivers. Manufacturers are increasingly enhancing powder formulations with advanced processing techniques to improve solubility, taste, and bioavailability of hydrolyzed proteins.

The segment’s dominance is further supported by its widespread availability in retail and healthcare distribution channels, catering to both mass-market and specialized nutritional needs Growing demand for lightweight, non-perishable products in emerging markets, coupled with the established consumer familiarity and trust in powder-based infant nutrition products, is expected to reinforce this segment’s market position in the forecast period.

Insights into the Offline Retail Distribution Channel Segment

The offline retail distribution channel segment is anticipated to account for 62.4% of the infant nutrition hydrolysate ingredients market revenue share in 2026, positioning it as the leading channel. Its dominance is supported by consumer preference for in-store product evaluation, brand comparison, and direct consultation with sales or healthcare professionals before purchase. Pharmacies, supermarkets, and specialty baby stores provide immediate product availability, reinforcing trust through physical presence and established brand credibility.

The segment is also benefiting from organized retail expansion in emerging economies, where improved store infrastructure and accessibility are increasing product reach. Manufacturers frequently leverage offline retail to offer promotions, in-store demonstrations, and personalized guidance, which are influential in purchasing decisions for sensitive infant nutrition products.

Despite the growth of e-commerce, the tactile and advisory aspects of offline retail continue to resonate strongly with caregivers seeking reassurance in product safety and authenticity This enduring preference for physical retail environments is expected to sustain the segment’s leading position.

Insights into the Infant Formula Application Segment

The infant formula application segment is expected to represent 36.7% of the infant nutrition hydrolysate ingredients market revenue share in 2026, making it the dominant application. This leadership is attributed to the increasing use of hydrolyzed proteins in infant formulas to address cow’s milk protein allergies, lactose intolerance, and digestive sensitivities in newborns and infants. The segment’s growth is supported by a rising emphasis on early nutritional intervention to promote optimal growth, immune development, and long-term health outcomes.

Technological advancements in enzymatic hydrolysis are improving ingredient digestibility and reducing allergenic potential while preserving essential amino acids and bioactive peptides. Regulatory recognition of hydrolyzed protein formulas as suitable for infants with specific health conditions is further driving adoption.

The segment also benefits from the growing premiumization of infant nutrition products, where parents are willing to invest in scientifically backed formulations that deliver proven health benefits With healthcare professionals increasingly recommending specialized formulas, the infant formula application is poised to remain the largest revenue contributor in this market.

What are the Drivers, Restraints, and Key Trends of the Infant Nutrition Hydrolysate Ingredients Market?

The infant nutrition hydrolysate ingredients market is expanding due to rising demand for hypoallergenic, digestible, and fortified infant formulas. North America and Europe lead adoption with advanced infant formula formulations, strict regulatory frameworks, and high consumer awareness of allergen management. Asia-Pacific shows rapid growth driven by increasing birth rates, urbanization, and rising disposable income. Manufacturers differentiate through protein hydrolysis degree, nutrient profile, and functional benefits. Regional differences in regulatory approvals, healthcare awareness, and formulation preferences strongly influence market adoption and competitiveness globally.

Hypoallergenic Formulations Drive Market Adoption

Adoption of hydrolysate ingredients is largely driven by the demand for hypoallergenic infant formulas that reduce the risk of allergic reactions. North America and Europe prioritize extensively hydrolyzed proteins and partially hydrolyzed proteins tailored for infants with milk protein sensitivities. Asia-Pacific markets are increasingly adopting hydrolyzed formulas for allergy prevention and digestive health in infants, particularly in urban and high-income populations. Differences in protein hydrolysis degree, formulation standards, and clinical validation affect ingredient selection, formula acceptance, and feeding efficacy. Leading suppliers provide standardized, high-purity protein hydrolysates with proven bioavailability and hypoallergenic performance, while regional manufacturers focus on cost-effective, locally compliant alternatives. Variations in allergy prevalence, consumer awareness, and clinical guidance directly shape adoption, product positioning, and competitive differentiation globally.

Nutritional Fortification and Digestive Health Influence Growth

Hydrolysate ingredients adoption is influenced by their role in supporting infant nutrition, digestive comfort, and growth. North America and Europe emphasize hydrolyzed proteins enriched with vitamins, minerals, prebiotics, and probiotics to enhance nutrient absorption and immune function. Asia-Pacific markets adopt hydrolysates optimized for gut health, digestibility, and formula palatability at competitive pricing. Differences in infant dietary requirements, formula regulation, and cultural feeding practices affect ingredient formulation, processing standards, and functional claims. Leading suppliers invest in research-backed hydrolysates with consistent peptide profiles and bioactive compounds, while regional players focus on safe, cost-efficient alternatives. Nutritional fortification contrasts shape adoption, product differentiation, and competitiveness in the global infant formula market.

Regulatory Approvals and Safety Standards Shape Adoption

Regulatory compliance and safety standards strongly influence the hydrolysate ingredients market. North America and Europe enforce stringent guidelines under FDA, EFSA, and Codex Alimentarius for protein hydrolysis, allergen labeling, and microbial safety. Asia-Pacific regulations vary, with developed markets following international norms and emerging regions implementing local approval processes. Differences in regulatory requirements, clinical substantiation, and labeling norms affect ingredient selection, market entry timelines, and product acceptance. Leading suppliers ensure compliance through certified, traceable, and lab-tested hydrolysates, while regional manufacturers focus on cost-effective solutions meeting basic safety standards. Regulatory contrasts shape adoption, product credibility, and competitive positioning across global infant nutrition markets.

Market Expansion Driven by Rising Birth Rates and Awareness

The growing birth rate and increasing parental awareness about infant health are major drivers for hydrolysate ingredient adoption. North America and Europe focus on specialized formulas for infants with allergies, digestive challenges, and nutritional deficiencies, supported by healthcare recommendations and clinical endorsements. Asia-Pacific markets experience rapid growth due to rising urban populations, higher disposable income, and greater demand for premium infant nutrition products. Differences in birth trends, healthcare guidance, and consumer purchasing power affect ingredient demand, formula innovation, and market penetration. Leading suppliers provide clinically validated, high-quality hydrolysates, while regional players offer cost-efficient alternatives. Population and awareness contrasts directly influence adoption, product development strategies, and market competitiveness globally.

Analysis of Infant Nutrition Hydrolysate Ingredients Market By Key Countries

Country	CAGR
China	8.6%
India	8.0%
Germany	7.4%
France	6.7%
UK	6.1%
USA	5.4%
Brazil	4.8%

The global infant nutrition hydrolysate ingredients market is projected to grow at a 6.4% CAGR through 2036, driven by demand in infant formula, clinical nutrition, and specialized dietary products. Among BRICS nations, China led with 8.6% growth as large-scale production and deployment across infant formula manufacturers were carried out, while India at 8.0% expanded manufacturing and adoption to support rising nutritional requirements. In the OECD region, Germany at 7.4% maintained steady integration under strict regulatory and safety standards, while the United Kingdom at 6.1% implemented hydrolysate ingredients across commercial and clinical nutrition products. The USA, growing at 5.4%, advanced utilization in infant and specialized nutrition applications while complying with federal and state-level food and safety regulations. This report includes insights on 40+ countries; the top countries are shown here for reference.

Infant Nutrition Hydrolysate Ingredients Market Expansion in China

The infant nutrition hydrolysate ingredients market in China is projected to grow at a CAGR of 8.6%, driven by increasing demand for hypoallergenic formulas, specialty infant nutrition, and functional ingredients. Adoption is being encouraged by ingredients that provide high digestibility, protein quality, and safety for infant consumption. Manufacturers are being urged to supply cost effective, reliable, and high quality products. Distribution through infant formula manufacturers, retail channels, and pharmaceutical suppliers is being strengthened. Research in protein hydrolysis techniques, allergen reduction, and nutrient fortification is being conducted. Rising awareness of infant allergies, increasing urban birth rates, and higher spending on premium nutrition are considered key factors driving the infant nutrition hydrolysate ingredients market in China.

• Hypoallergenic formula demand boosted adoption
• High digestibility and safe ingredients were supplied
• R&D focused on allergen reduction and protein hydrolysis

Infant Nutrition Hydrolysate Ingredients Market Growth in India

In India, the infant nutrition hydrolysate ingredients market is expected to grow at a CAGR of 8.0%, supported by adoption in infant formula, clinical nutrition, and fortified milk products. Emphasis is being placed on ingredients that provide digestibility, protein quality, and safety. Local manufacturers are being encouraged to enhance production capabilities and offer cost effective, high quality solutions. Distribution through formula manufacturers, hospitals, and retail channels is being expanded. Awareness campaigns promoting infant nutrition and hypoallergenic benefits are being conducted. Increasing infant population, growing health consciousness among parents, and rising demand for premium nutrition products are recognized as primary drivers of the infant nutrition hydrolysate ingredients market in India.

• Infant formula adoption increased demand
• High quality and safe ingredients were supplied
• Campaigns promoted hypoallergenic benefits

Infant Nutrition Hydrolysate Ingredients Market Insights in Germany

Germany is witnessing steady growth in the infant nutrition hydrolysate ingredients market at a CAGR of 7.4%, driven by demand from infant formula manufacturers, hospitals, and specialty nutrition providers. Adoption is being encouraged by ingredients that ensure protein digestibility, nutritional balance, and compliance with European safety standards. Manufacturers are being urged to supply advanced, high quality, and safe ingredients. Distribution through formula companies, pharmacies, and retail chains is being optimized. Research in protein hydrolysis, nutrient fortification, and allergen control is being pursued. Rising demand for hypoallergenic products, growing health awareness, and premium nutrition trends are considered key factors driving the infant nutrition hydrolysate ingredients market in Germany.

• Hypoallergenic product demand supported adoption
• Safe and high quality ingredients were supplied
• R&D focused on protein hydrolysis and nutrient fortification

Infant Nutrition Hydrolysate Ingredients Market Overview in the United Kingdom

The infant nutrition hydrolysate ingredients market in the United Kingdom is projected to grow at a CAGR of 6.1%, supported by demand from infant formula, clinical nutrition, and specialized milk products. Adoption is being emphasized for ingredients that provide digestibility, safety, and high protein quality. Manufacturers are being encouraged to supply reliable, high quality, and safe ingredients. Distribution through formula manufacturers, retail pharmacies, and hospitals is being strengthened. Awareness programs highlighting infant nutrition benefits and hypoallergenic properties are being conducted. Increasing birth rates, parental focus on infant health, and premium nutrition demand are recognized as major contributors to the infant nutrition hydrolysate ingredients market in the United Kingdom.

• Formula and specialized milk demand boosted adoption
• High quality and safe ingredients were supplied
• Awareness programs promoted hypoallergenic nutrition

Infant Nutrition Hydrolysate Ingredients Market Trends in the United States

The infant nutrition hydrolysate ingredients market in the United States is projected to grow at a CAGR of 5.4%, driven by demand from formula manufacturers, hospitals, and specialty nutrition providers. Adoption is being encouraged by ingredients that ensure protein quality, digestibility, and compliance with safety standards. Manufacturers are being urged to develop advanced, reliable, and high quality solutions. Distribution through formula companies, retail channels, and healthcare providers is being maintained. Research in protein hydrolysis, allergen reduction, and nutrient enrichment is being pursued. Rising health awareness, increasing demand for hypoallergenic products, and growing infant formula consumption are considered key drivers of the infant nutrition hydrolysate ingredients market in the United States.

• Infant formula and clinical nutrition increased adoption
• Reliable and high quality ingredients were developed
• R&D focused on allergen reduction and nutrient enrichment

Competitive Landscape of Infant Nutrition Hydrolysate Ingredients Market

The infant nutrition hydrolysate ingredients market is dominated by a group of global leaders who have established strong footholds through extensive research, high-quality products, and broad distribution networks. Key suppliers in this market include Nestle S.A., Danone S.A., Abbott Laboratories, Mead Johnson Nutrition (now RB Health), FrieslandCampina, Arla Foods Ingredients Group, Glanbia plc, Kerry Group plc, DSM Nutritional Products, Chr. Hansen Holding A/S, Fonterra Co-operative Group Limited, Palsgaard A/S, Tatua Co-operative Dairy Company Ltd., Lactalis Ingredients, and Carbery Group. These companies focus on delivering specialized hydrolysate proteins that cater to the nutritional needs of infants, particularly in hypoallergenic formulas and digestive-sensitive applications.

Their products are used extensively in infant formulas, toddler nutrition products, and functional dairy-based foods, emphasizing safety, digestibility, and optimal nutrient bioavailability. Market growth is largely driven by increasing awareness among parents about infant allergies, intolerances, and the need for specialized nutrition. Suppliers such as Nestle S.A., Danone S.A., Abbott Laboratories, and FrieslandCampina have been at the forefront of innovation, developing partially hydrolyzed and extensively hydrolyzed protein formulations designed to reduce allergenicity while maintaining essential nutritional profiles.

Arla Foods Ingredients Group, Glanbia plc, and Kerry Group plc have also contributed to the market by focusing on clean-label ingredients and high-quality whey and casein protein hydrolysates, ensuring compliance with stringent international safety and quality standards. These companies leverage advanced enzymatic processes and stringent quality controls to provide consistent and reliable ingredient solutions for infant nutrition manufacturers worldwide. In addition to innovation and quality, sustainability and supply chain efficiency are critical factors shaping market leadership.

DSM Nutritional Products, Chr. Hansen Holding A/S, Fonterra, and Lactalis Ingredients have emphasized sustainable sourcing, reduced environmental footprint, and traceable supply chains to meet evolving consumer expectations and regulatory requirements. Furthermore, companies like Palsgaard A/S, Tatua Co-operative Dairy Company Ltd., and Carbery Group have strengthened their market positions through collaborations with infant formula manufacturers, enabling co-development of tailored hydrolysate solutions. The combination of cutting-edge research, high-quality production, and strong industry partnerships ensures that these suppliers remain at the forefront of the infant nutrition hydrolysate ingredients market, driving innovation, consumer trust, and long-term growth.

Key Players in the Infant Nutrition Hydrolysate Ingredients Market

• Nestle S.A.
• Danone S.A.
• Abbott Laboratories
• Mead Johnson Nutrition (now RB Health)
• FrieslandCampina
• Arla Foods Ingredients Group
• Glanbia plc
• Kerry Group plc
• DSM Nutritional Products
• Chr. Hansen Holding A/S
• Fonterra Co-operative Group Limited
• Palsgaard A/S
• Tatua Co-operative Dairy Company Ltd.
• Lactalis Ingredients
• Carbery Group

Scope of the Report

Metric	Value
Quantitative Units	USD 369.21 Million to USD 686.57 Million, at a CAGR of 6.40%
Market Definition	Infant nutrition hydrolysate ingredients are enzymatically hydrolyzed protein preparations specifically manufactured for use in hypoallergenic infant formula, baby food, and clinical pediatric nutrition products. These ingredients deliver pre-digested protein peptides that reduce allergenic potential in infants with confirmed or suspected cow milk protein allergy (CMPA).
Form Segmentation	Powder, Liquid
Distribution Channel Segmentation	Offline Retail, Online Retail
Application Segmentation	Infant Formula, Baby Food, Clinical Nutrition, Others
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	China, India, Germany, France, UK, USA, Brazil, and 40 plus countries
Key Companies Profiled	Nestle S.A., Danone S.A., Abbott Laboratories, Mead Johnson Nutrition (now RB Health), FrieslandCampina, Arla Foods Ingredients Group, Glanbia plc, Kerry Group plc, DSM Nutritional Products, Chr. Hansen Holding A/S
Forecast Period	2026 to 2036
Approach	Hybrid top-down and bottom-up modeling with cross-validation against public trade data and company disclosures.

Infant Nutrition Hydrolysate Ingredients Market by Segments

Form:

• Powder
• Liquid

Distribution Channel:

• Offline Retail
• Online Retail

Application:

• Infant Formula
• Baby Food
• Clinical Nutrition
• Others

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Bibliography

• European Food Safety Authority. (2024). Scientific opinion on the safety and suitability of protein hydrolysates for use in infant formula. EFSA Journal.
• Codex Alimentarius Commission. (2024). Standard for infant formula (CXS 72-1981, revised). FAO/WHO.
• World Health Organization. (2024). Guidelines on cow milk protein allergy management in infants. WHO.
• U.S. Food and Drug Administration. (2024). Infant formula requirements: Protein hydrolysate ingredient specifications (21 CFR 107). FDA.
• ESPGHAN. (2024). Position paper on hydrolysed formula for CMPA management. JPGN.
• Nestle S.A. (2024). Annual report 2024: Infant nutrition segment review. Nestle Investor Relations.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.